◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › PRFX

PRF Technologies Ltd. (PRFX) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-07-09

PRF Technologies Ltd. (PRFX) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Tel Aviv-Yafo, Israel with about 6 employees. Its market capitalization is roughly $4 million. In the fiscal year ended 2025-12-31, PRFX reported $0M in revenue and ($5M) in net income.

PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel.

Interactive charts & full statements → Open the PRFX valuation workbench →

PRFX Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$0M$0M$0M$0M
Gross Profit($0M)$0M$0M
Operating Income (EBIT)($5M)($15M)($10M)($9M)
Net Income($5M)($15M)($9M)($9M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PRFX Free Cash Flow History

PRFX Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$12M$4M$10M$12M
Total Liabilities$3M$3M$3M$1M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PRFX viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← PREAll stocksPRG →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.